InvestorsHub Logo
Followers 16
Posts 3124
Boards Moderated 1
Alias Born 11/09/2006

Re: None

Wednesday, 09/14/2016 5:13:09 PM

Wednesday, September 14, 2016 5:13:09 PM

Post# of 18304
NeoGenomics License

On January 6, 2012, we entered into a Master License Agreement (the “NeoGenomics License”) with NeoGenomics Laboratories, Inc. (“NeoGenomics Laboratories”), a wholly owned subsidiary of NeoGenomics, Inc. (“NeoGenomics”). Pursuant to the terms of the NeoGenomics License, we granted to NeoGenomics Laboratories and its affiliates an exclusive worldwide license to certain of our patents and know-how to use, develop and sell products in the fields of laboratory testing, molecular diagnostics, clinical pathology, anatomic pathology and digital image analysis (excluding non-pathology-related radiologic and photographic image analysis) relating to the development, marketing production or sale of any “Laboratory Developed Tests” or LDTs or other products used for diagnosing, ruling out, predicting a response to treatment, and/or monitoring treatment of any or all hematopoietic and solid tumor cancers excluding cancers affecting the retina and breast cancer. We retain all rights to in-vitro diagnostic (“IVD”) test kit development.

As I stated in recent days about the IVD kits - if you read the RB message board you can see where BQ reports that the time to develop/market the IVD Kits are years away so why in the world mention how great the IVD Kits were to be. Simple! they had no clue when they first broke the PR a few years back or MORE!

About NEO compensation before payment as I understand it - I will try and find that right now, OH I have 243k shares of HDC rotting away.

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=124695276







Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HDVY News